Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
FONR logo FONR
Upturn stock ratingUpturn stock rating
FONR logo

Fonar Corporation (FONR)

Upturn stock ratingUpturn stock rating
$15.16
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

01/14/2025: FONR (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Moderate Performance

These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.

Analysis of Past Performance

Type Stock
Historic Profit 1.01%
Avg. Invested days 37
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 3.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 01/14/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 95.29M USD
Price to earnings Ratio 10.64
1Y Target Price -
Price to earnings Ratio 10.64
1Y Target Price -
Volume (30-day avg) 10924
Beta 1.19
52 Weeks Range 14.05 - 24.05
Updated Date 01/12/2025
52 Weeks Range 14.05 - 24.05
Updated Date 01/12/2025
Dividends yield (FY) -
Basic EPS (TTM) 1.4

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 10.27%
Operating Margin (TTM) 5.14%

Management Effectiveness

Return on Assets (TTM) 4.98%
Return on Equity (TTM) 9.17%

Valuation

Trailing PE 10.64
Forward PE -
Enterprise Value 83667576
Price to Sales(TTM) 0.94
Enterprise Value 83667576
Price to Sales(TTM) 0.94
Enterprise Value to Revenue 0.82
Enterprise Value to EBITDA 3.18
Shares Outstanding 6271660
Shares Floating 5846309
Shares Outstanding 6271660
Shares Floating 5846309
Percent Insiders 2.42
Percent Institutions 49.78

AI Summary

Fonar Corporation: A Comprehensive Overview

Company Profile

History and Background

Founded in 1978 by Raymond Damadian, Fonar Corporation is a medical device company specializing in Magnetic Resonance Imaging (MRI) technology. Dr. Damadian pioneered the MRI concept, and Fonar has since become a leading manufacturer of high-field open MRI scanners.

Fonar's journey hasn't been smooth. The company faced financial difficulties in the 1990s and 2000s, but it has emerged as a key player in the open MRI market. Today, Fonar focuses on developing innovative and affordable MRI technology for various medical applications.

Core Business Areas

Fonar's core business areas are:

  • Manufacturing and selling open MRI scanners: These scanners offer a more comfortable experience for patients, particularly those with claustrophobia, as they are open on all sides.
  • Developing new MRI technologies: Fonar continuously invests in research and development to enhance the capabilities and affordability of its MRI systems.
  • Providing service and support: Fonar offers comprehensive service and support to its customers, ensuring optimal performance and uptime of their MRI scanners.

Leadership and Corporate Structure

The current leadership team of Fonar Corporation includes:

  • Raymond V. Damadian, Ph.D.: Founder, Chairman, and Chief Visionary Officer
  • Thomas R. Horn: President and Chief Executive Officer
  • David A. DeMeo, CPA: Chief Financial Officer

Fonar operates under a traditional corporate structure with a Board of Directors overseeing the company's strategic direction.

Top Products and Market Share

Top Products

Fonar's top products include:

  • Upright MRI Scanner: This scanner allows patients to be scanned in a standing position, which is beneficial for specific medical conditions.
  • Open MRI Scanner: This scanner provides a more comfortable experience for patients with claustrophobia.
  • 7 Tesla MRI Scanner: This high-field scanner offers superior image quality and faster scanning times.

Market Share

Fonar holds a significant market share in the open MRI segment, particularly in the United States. However, the overall MRI market is dominated by larger players like GE Healthcare, Siemens Healthineers, and Philips.

Competitive Landscape

Fonar faces competition from major medical device companies in the MRI market. While Fonar excels in open MRI technology, its competitors offer a wider range of MRI systems and advanced imaging capabilities.

Total Addressable Market

The global MRI market was valued at USD 7.8 billion in 2022 and is expected to reach USD 12.5 billion by 2028, growing at a CAGR of 8.5%. The increasing demand for early disease diagnosis and the growing prevalence of chronic diseases are driving this market growth.

Financial Performance

Fonar's recent financial performance has been mixed. The company has reported losses in recent years, but revenue has been increasing.

Key financial metrics as of October 27, 2023:

  • Revenue (TTM): $34.5 million
  • Net Loss (TTM): $13.6 million
  • EPS (TTM): -$0.45
  • Cash and Equivalents: $14.7 million
  • Debt (Total): $22.8 million

Dividends and Shareholder Returns

Fonar does not currently pay dividends. Since the company is not profitable, it is unlikely to initiate dividend payments in the near future.

Growth Trajectory

Fonar's historical growth has been volatile, with periods of significant revenue increases followed by declines. The company's future growth prospects depend on its ability to successfully launch new products, expand its market share, and improve profitability.

Market Dynamics

The MRI market is characterized by:

  • Technological advancements: Continuous innovation in MRI technology is driving the development of faster, more powerful, and more affordable scanners.
  • Increased demand for early diagnosis: The rising prevalence of chronic diseases is increasing the demand for early diagnosis, which is driving the adoption of MRI technology.
  • Competitive landscape: The MRI market is dominated by a few large players, but there are also several smaller players, including Fonar, focusing on niche segments.

Competitors

Fonar's main competitors in the MRI market include:

  • GE Healthcare (GE)
  • Siemens Healthineers (SHG)
  • Philips (PHG)
  • Hitachi Medical Systems (Hit)
  • Toshiba Medical Systems (Tos)

Potential Challenges and Opportunities

Challenges

  • Intense competition from larger players with broader product offerings and advanced technologies.
  • Maintaining profitability in a competitive market with pressure on pricing.
  • Adapting to rapid technological advancements and keeping up with the latest innovations.

Opportunities

  • Growing demand for MRI technology in emerging markets.
  • Expanding into new market segments, such as veterinary imaging and interventional procedures.
  • Developing new and innovative MRI technologies to differentiate itself from competitors.

Recent Acquisitions

About NVIDIA Corporation

Exchange NASDAQ
Headquaters Melville, NY, United States
IPO Launch date 1987-01-01
Chairman, President, CEO & Treasurer Mr. Timothy R. Damadian M.D.
Sector Healthcare
Industry Diagnostics & Research
Full time employees 520
Full time employees 520

FONAR Corporation, together with its subsidiaries, engages in the designing, manufacturing, and selling magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries in the United States. It operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. The company offers Upright MRI scanner, allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. It also provides non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. In addition, the company owns and operates diagnostic imaging facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1978 and is based in Melville, New York.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​